Kalos Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,521
Closed -$1.33M 149
2017
Q2
$1.33M Buy
6,521
+45
+0.7% +$8.96K 1.22% 32
2017
Q1
$1.18M Buy
6,476
+666
+11% +$116K 0.84% 43
2016
Q4
$932K Buy
5,810
+644
+12% +$94.6K 0.75% 48
2016
Q3
$729K Sell
5,166
-621
-11% -$86.5K 0.62% 53
2016
Q2
$789K Buy
5,787
+461
+9% +$61.2K 0.61% 58
2016
Q1
$798K Hold
5,326
0.66% 55
2015
Q4
$798K Buy
+5,326
New +$787K 0.6% 55

Other funds holding CHE

Kalos Management's CHE Position: Q3 2017 in Review

Kalos Management sold out of Chemed (CHE) in Q3 2017, closing a stake of 6,521 shares — an estimated $1.33M sold.

Kalos Management first reported a position in CHE in Q4 2015 and held it in 7 quarters. The position peaked at $1.33M in Q2 2017. 259 funds tracked by Wall St. Rank hold CHE as of Q3 2017.

  • Kalos Management reported no remaining Chemed position as of Q3 2017 after selling out during the quarter.
  • Kalos Management sold 6,521 Chemed shares in Q3 2017, an estimated $1.33M.
  • Kalos Management first reported a position in Chemed in Q4 2015 and held it in 7 quarters.
  • Kalos Management's Chemed position peaked at $1.33M in Q2 2017.
  • 259 funds tracked by Wall St. Rank held Chemed as of Q3 2017.

Based on Kalos Management's 13F filing for Q3 2017, filed 14 Nov 2017.